The Best Is Yet To Come For UNGS – Must Read Final Report!


Hi Everyone & Welcome New Subscribers,

Our profiled pick UNGSSylios Corp., continues to hold higher above our initial alert price nearly two months ago, after surging for 100% gains shortly after our first profile, and remains on high alert as our most favorite mid-long term pick!

If you bought UNGS just one month ago when we suggested taking a look at the stock, you would still be up 50% at current prices, with the opportunity to double your money in just over a week!

Dare we say, however, that the best is yet to come for UNGS?

Just this past week, UNGS announced their retention of an auditor to aid them in the process of uplisting to the OTCQB, and becoming a fully reporting company over the next 90-120 days!

Read this press release in it’s entirety, HERE!

That means over the next 90-120 days, UNGS anticipates a bid price of .01 or more (with recent changes to OTCQB uplisting requirements), which would represent a gain of more than 350% from Friday’s close!

UNGS expects to reach an agreement to acquire Signifi this month, a global leader in automated retail solutions, and has been an innovator in the industry for over ten years. Signifi projects revenues of $5 million USD for 2014, and is projecting future revenues of $50 million USD from leading online and brick and mortar retail customers.

UNGS also plans on launching a retail website for their new recreational and medical marijuana subsidiary, The Greater Cannabis Company, at, and also expects to launch their new corporate website for Sylios Corp. ( in the very near term. Signifi plans to focus on medical wellness and medical marijuana dispensing solutions upon being acquired by UNGS, and their high-end, automated retail kiosk solutions is the exact cutting edge technology the medical marijuana dispensing industry needs, and could rival the likes of companies such as AVTC (AVT, Inc.), ERBB (American Green, Inc.), and MDBX (Medbox, Inc.), which have market caps ranging from 40 to 400 times larger than UNGS!

That statistic alone is baffling! Don’t believe us? See for yourself

AVTC – $40M+ Market Value

ERBB – $60M+ Market Value

MDBX – $400M+ Market Value

UNGS announced on April 30th their plans to close the acquisition with Signifi by July 30th, which means this week things could get VERY exciting!

If you haven’t looked at UNGS, now may be the time!


Happy Trading!


The Penny Stock Experts Team At 

Please read our legal Disclaimer below:

This disclaimer is to be read in its entirety, and fully understood before using or joining the email list. reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Your continued use of the website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS. Neither nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st
ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site. We are neither licensed nor qualified to provide investment advice.

The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website. Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. and/or it’s affiliates may receive compensation for e-mail alerts. To view our full compensation disclosure please visit does not accept free-trading shares as a form of payment. 

We have NOT been compensated for any e-mails, “tweets”, or blog posts related to UNGS, nor do we plan to be in the future. We have no communication with the company or insiders, nor do we plan to. We have purchased up to, but not exceeding, 5,000,000 shares of UNGS stock on the open market, which we plan to trade as we see fit. If unforeseen events (which are out of our control) affect UNGS, we may sell our entire position at any time.